China National Accord Medicines Corporation Ltd. (SHE:000028)

SHE:000028 Revenue

China National Accord Medicines Corporation had revenue of 18.44B CNY in the quarter ending June 30, 2026, a decrease of -0.32%. This brings the company's total for the last twelve months to 72.89B, down -0.69% year-over-year. In the year 2025, China National Accord Medicines Corporation had annual revenue of 73.42B, down -1.29%. That makes China National Accord Medicines Corporation the 1,374th largest company in the world by revenue and 129th in China.

• Revenue (ttm): 72.89B
• Revenue Growth: -0.69%
• P/S Ratio: 0.16
• Revenue / Employee: 1.85M
• Employees: 39,449
• Market Cap: 11.81B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Distribution 53.32B 71.8%
• Retail 20.98B 28.2%
• Headquarters 7.71M 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:000028 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.42B	-962.64M	-1.29%
Dec 31, 2024	74.38B	-1.10B	-1.46%
Dec 31, 2023	75.48B	2.03B	2.77%
Dec 31, 2022	73.44B	5.09B	7.44%
Dec 31, 2021	68.36B	8.71B	14.60%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error